Compare Stocks

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

First Trust Value Line 100 Exchange-Traded Fund (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Value Line 100 Index (the Index). The Index is an equal-dollar weighted index that is designed to objectively identify and select 100 stocks from the universe of stocks, to which Value Line assigns a #1 ranking in the Value Line Timeliness Ranking System (the Ranking System). At any one time, only 100 stocks are assigned a #1 ranking in the Ranking System. The Index is rebalanced quarterly. The Fund will normally invest at least 90% of its assets in common stocks that comprise the Index. The Fund's investment advisor is First Trust Advisors L.P.

Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Roscan Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in West Africa. It holds 100% interests in the Kandiole project comprising ten contiguous gold exploration permits covering an area of approximately 401.8 square kilometers located in Mali, West Africa. The company was formerly known as Roscan Minerals Corporation and changed its name to Roscan Gold Corporation in September 2018. Roscan Gold Corporation was incorporated in 1987 and is headquartered in Toronto, Canada.

Wealth Minerals Ltd., a junior mineral resource exploration company, engages in the acquisition, exploration, and development of mineral properties in Canada, Chile, Peru, and Mexico. The company primarily explores for lithium, as well as for precious metal and copper deposits. Its flagship property is the 100% owned Atacama project that comprises 144 exploration concessions covering an area of approximately 46,200 hectares located in the Atacama Salar in Region II of Antofagasta, northern Chile. Wealth Minerals Ltd. was incorporated in 1994 and is headquartered in Vancouver, Canada.